Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Infusion for Cerebral Protection in Children After Congenital Heart Defect Surgery
NCT06525584Recruiting
- Sponsor
- Kemerovo State Medical University
- Start
- Nov 2023
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ketamine in traumatic brain injury (TBI) (3 arms), sponsored by Kemerovo State Medical University. Primary endpoint: Biomarkers at 16 hours. Started Nov 2023; status: recruiting.
02
Drugs
ketamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06525584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06525584.